HER2 Support Group Forums - View Single Post - Combination of cetuximab and cisplatin chemotherapy benefits women with triple-negati

News · 10-12-2010, 09:50 PM

European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer.

More...

10-12-2010, 09:50 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,147	Combination of cetuximab and cisplatin chemotherapy benefits women with triple-negati European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer. More...